Severe necrotizing myopathy after COVID‐19 vaccine with BNT162b2 and regimen with ipilimumab plus nivolumab in a patient with advanced melanoma
Mickaël Blaise(Université Côte d'Azur), Henri Montaudié(Hôpital l'Archet), Thierry Passeron(Inserm), Angela Puma(Université Côte d'Azur), Adrien Sanchez(Université Côte d'Azur), Fanny Rocher(Université Côte d'Azur), Arnaud Martel(Université de Sherbrooke), Géraldine Gonfrier(Université Côte d'Azur), Hélène Spittler(Université Côte d'Azur), Lucio Lo Coco(Université Côte d'Azur), Elisabeth Lantéri(Université Côte d'Azur)
Cited by 14
Related Papers
Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo
|Nature Communications|2019|175
Single-cell RNA sequencing reveals intratumoral heterogeneity in primary uveal melanomas and identifies HES6 as a driver of the metastatic disease
|Cell Death and Differentiation|2021|109
Efficacy of Immunotherapy in Patients with Metastatic Mucosal or Uveal Melanoma
|Journal of Oncology|2018|82